Utility of PSMA-PET imaging

被引：0
|
作者：
Ahmadzadehfar, Hojjat [1 ]
Biersack, Hans Jurgen [2 ]
机构：
[1] Klinikum Westfalen, Klin Nukl Med, Dortmund, Germany
[2] Univ Klinikum Bonn, Klin Nukl Med, Bonn, Germany
来源：
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2021年 / 118卷 / 35-36期
关键词：
D O I：
10.3238/arztebl.m2021.0234
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：603 / 603
页数：1
相关论文
共 50 条
  • [41] Integration of PSMA-PET Imaging in the Radiation Treatment Planning- primary definitive Radiotherapy in Prostate Cancer
    Dewes, S.
    Schiller, K.
    Sauter, K.
    Eiber, M.
    Maurer, T.
    Schwaiger, M.
    Gschwend, J. E.
    Combs, S. E.
    Habl, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 : S56 - S56
  • [42] E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
    Ceci, Francesco
    Oprea-Lager, Daniela E.
    Emmett, Louise
    Adam, Judit A.
    Bomanji, Jamshed
    Czernin, Johannes
    Eiber, Matthias
    Haberkorn, Uwe
    Hofman, Michael S.
    Hope, Thomas A.
    Kumar, Rakesh
    Rowe, Steven P.
    Schwarzenboeck, Sarah M.
    Fanti, Stefano
    Herrmann, Ken
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (05) : 1626 - 1638
  • [43] E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
    Francesco Ceci
    Daniela E. Oprea-Lager
    Louise Emmett
    Judit A. Adam
    Jamshed Bomanji
    Johannes Czernin
    Matthias Eiber
    Uwe Haberkorn
    Michael S. Hofman
    Thomas A. Hope
    Rakesh Kumar
    Steven P. Rowe
    Sarah M. Schwarzenboeck
    Stefano Fanti
    Ken Herrmann
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1626 - 1638
  • [44] Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
    Jannusch, Kai
    Bruckmann, Nils Martin
    Morawitz, Janna
    Boschheidgen, Matthias
    Quick, Harald H.
    Herrmann, Ken
    Fendler, Wolfgang P.
    Umutlu, Lale
    Stuschke, Martin
    Hadaschik, Boris
    Antoch, Gerald
    Schimmoeller, Lars
    Kirchner, Julian
    EUROPEAN RADIOLOGY, 2024, 34 (07) : 4789 - 4800
  • [45] Primary staging with PSMA-PET improves the prediction of prostate cancer recurrence
    Yirga, Leubet
    Hadaschik, Boris
    Puellen, Lukas
    UROLOGIE, 2023, : 1326 - 1327
  • [46] PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer?
    Laura Evangelista
    Pierpaolo Alongi
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1709 - 1711
  • [47] Uncovering multifocality - PSMA-PET radiomic features for detection of intraprostatic microlesions
    Bettermann, A. S.
    Spohn, S.
    Kiefer, S.
    Jilg, C. A.
    Kranz-Rudolph, J.
    Fassbender, T. F.
    Bronsert, P.
    Nicolay, N. H.
    Mix, M.
    Ruf, J.
    Benndorf, M.
    Grosu, A. L.
    Zamboglou, C.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S371 - S372
  • [48] Emotional state of patients with prostate cancer during PSMA-PET/CT
    Boeser, J.
    Faller, H.
    Lukasczik, M.
    Weisbrodt, J.
    Werner, R. A.
    Buck, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S692 - S692
  • [49] Nuklearmedizinische Diagnostik und Therapie des ProstatakarzinomsWer braucht wann ein PSMA-PET? Gibt es einen Stellenwert für die PSMA-Therapie?Nuclear medical diagnostics and treatment of prostate cancerWho needs PSMA-PET imaging and when? Is there a need for PSMA therapy?
    Michael Grunert
    Nina Eberhardt
    Vikas Prasad
    Ambros J. Beer
    Journal für Urologie und Urogynäkologie/Österreich, 2021, 28 (2): : 58 - 72
  • [50] Defining the clinical utility of PSMA-targeted PET imaging of prostate cancer
    Gorin, Michael A.
    Pomper, Martin G.
    Pienta, Kenneth J.
    Rowe, Steven P.
    BJU INTERNATIONAL, 2017, 120 (02) : 160 - 161
12345